| abstract |
The invention relates to the use of a pharmaceutical medication that contains an aromatase inhibitor, preferably a steroidal aromatase inactivator, and an antioxidant as active ingredients for treating sexual hormone-dependent diseases. The invention further relates to a composition that contains an aromatase inhibitor/inactivator and a-lipoic acid and/or green tea extract containing polyphenols. The combination of an aromatase inhibitor or inactivator and a-lipoic acid and/or green tea extract containing polyphenols is particularly suitable for treating sexual hormone-dependent diseases and for treating benign tumors such as lipomas, for example, such as those which occur in cases of benign symmetric lipomatosis. |